Kynam Capital Management, LP Argenx Se Transaction History
Kynam Capital Management, LP
- $1.58 Billion
- Q4 2024
A detailed history of Kynam Capital Management, LP transactions in Argenx Se stock. As of the latest transaction made, Kynam Capital Management, LP holds 184,300 shares of ARGX stock, worth $118 Million. This represents 9.88% of its overall portfolio holdings.
Number of Shares
184,300Holding current value
$118 Million% of portfolio
9.88%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ARGX
# of Institutions
428Shares Held
29.2MCall Options Held
389KPut Options Held
270K-
Price T Rowe Associates Inc Baltimore, MD5.52MShares$3.53 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.96 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.48 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.79MShares$1.14 Billion0.17% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$792 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.4B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...